|

Evaluation of HEArt invoLvement in Patients With FABRY Disease

RECRUITINGSponsored by Wuerzburg University Hospital
Actively Recruiting
SponsorWuerzburg University Hospital
Started2001-01
Est. completion2032-03
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT03362164

Summary

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Fabry disease (genetically confirmed)
* Signed informed consent
* 18 years and older

Exclusion Criteria:

* No informed consent
* Withdrawal of informed consent

Conditions5

Fabry DiseaseFabry Disease, Cardiac VariantHeart DiseaseHypertrophic CardiomyopathyRare Diseases

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.